Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 29 May 20 425 Business combination disclosure
- 27 May 20 425 Business combination disclosure
- 12 May 20 425 Business combination disclosure
- 11 May 20 425 Business combination disclosure
- 30 Apr 20 425 Business combination disclosure
-
25 Mar 20 425 Business combination disclosure
- 17 Mar 20 425 Business combination disclosure
- 16 Mar 20 425 Business combination disclosure
- 16 Mar 20 425 Business combination disclosure
TLPH similar filings
Related company
Filing view
External links
Filed by AcelRx Pharmaceuticals, Inc.
(Commission File No. 001-35068)
pursuant to Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule 14a-12
under the Securities Exchange Act of 1934
Subject Company: Tetraphase Pharmaceutials, Inc.
(Commission File No. 001-35837